The view shows ampoules of "component 1" and "component 2" of the two-component vector vaccine the Sputnik-V against coronavirus infection, in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.
